Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness

Front Cell Dev Biol. 2020 Oct 2:8:594589. doi: 10.3389/fcell.2020.594589. eCollection 2020.

Mei-Yu Quan¹, Qiang Guo¹, Jiayu Liu², Ruo Yang¹, Jing Bai¹, Wei Wang¹, Yaxin Cai², Rui Han¹, Yu-Qing Lv³, Li Ding⁴, Daniel D Billadeau⁴, Zhenkun Lou⁴, Saverio Bellusci^{2

5}, Xiaokun Li¹, Jin-San Zhang^{1

2}

¹ School of Pharmaceutical Sciences and International Collaborative Center on Growth Factor Research, Wenzhou Medical University, Wenzhou, China.
² Institute of Life Sciences, Wenzhou University, Wenzhou, China.
³ Center for Precision Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
⁴ Division of Oncology Research and Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, United States.
⁵ Cardio-Pulmonary Institute, Member of the German Lung Center, Justus Liebig University Giessen, Giessen, Germany.

Abstract

[This corrects the article DOI: 10.3389/fcell.2020.00287.].

Keywords: FGFR; SOX2; pancreatic cancer; sphere-formation assay; stemness.